1. Home
  2. GDRX vs ORIC Comparison

GDRX vs ORIC Comparison

Compare GDRX & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

HOLD

Current Price

$3.60

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$13.61

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDRX
ORIC
Founded
2011
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
GDRX
ORIC
Price
$3.60
$13.61
Analyst Decision
Hold
Strong Buy
Analyst Count
14
16
Target Price
$3.95
★ $21.64
AVG Volume (30 Days)
878.1K
★ 1.4M
Earning Date
11-03-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 125.00
19.67
EPS
★ 0.03
N/A
Revenue
★ $796,853,000.00
N/A
Revenue This Year
$0.20
N/A
Revenue Next Year
$4.72
N/A
P/E Ratio
$119.33
★ N/A
Revenue Growth
★ 0.57
N/A
52 Week Low
$1.77
$7.23
52 Week High
$4.05
$14.68

Technical Indicators

Market Signals
Indicator
GDRX
ORIC
Relative Strength Index (RSI) 60.70 59.43
Support Level $3.26 $13.12
Resistance Level $3.89 $14.22
Average True Range (ATR) 0.12 0.83
MACD 0.03 0.20
Stochastic Oscillator 91.46 79.32

Price Performance

Historical Comparison
GDRX
ORIC

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: